Pharmacokinetics, pharmacodynamics, and  tolerability of JY09 in healthy Chinese subjects: A titrating, dose-escalating study
.

CONCLUSION: JY09 has a long half-life of ~ 9.3 days, with an acceptable safety profile. PMID: 32729820 [PubMed - as supplied by publisher]
Source: International Journal of Clinical Pharmacology and Therapeutics - Category: Drugs & Pharmacology Tags: Int J Clin Pharmacol Ther Source Type: research